Richard Brudnick

CIK 1692359 · Chief Business Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.06M

Companies

5

Total Filings

26

Lifetime Open-Market Net

-$156.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRRK Director 21,896 $44.18 $967.4K -$180.5K 5 2026-06-08
PRME Chief Business Officer 20,000 $2.77 $55.5K $23.8K 6 2025-05-22
VNRX Director 27,936 $1.38 $38.6K $0 5 2023-01-13
Codiak BioSciences, Inc. (CDAK) Delisted See Remarks $0.06 $0 3 2022-02-18
Bioverativ Inc. (BIVV) Delisted EVP, Business Development 0 $0 7 2018-03-08

Recent Filings · Page 3 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-02-26 Bioverativ Inc. (BIVV) Delisted Tax (F) −2,343 -$244.8K EDGAR
2018-02-15 Bioverativ Inc. (BIVV) Delisted Mixed +2,607 -$117.7K EDGAR
2018-02-02 Bioverativ Inc. (BIVV) Delisted Grant (A) $0 EDGAR
2017-03-27 Bioverativ Inc. (BIVV) Delisted Grant (A) $0 EDGAR
2017-03-02 Bioverativ Inc. (BIVV) Delisted Mixed +22,431 -$226.2K EDGAR
2017-02-16 Bioverativ Inc. (BIVV) Delisted Grant (A) $0 EDGAR
Showing 2126 of 26
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.